Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

NCT01567527 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

731

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: Intramuscular (IM) Depot Aripiprazole
DRUG: Intramuscular (IM) Depot Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]